Powder: -20°C for 3 years | In solvent: -80°C for 1 year
ABT-925 is a selective dopamine D3 receptor (DRD3) antagonist with an in vitro affinity approximately 100 times higher for dopamine D3 receptors than for D2 receptors.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
25 mg | 約6-8 週間 | ¥ 383,500 |
50 mg | 約6-8 週間 | ¥ 500,500 |
100 mg | 約6-8 週間 | ¥ 643,000 |
説明 | ABT-925 is a selective dopamine D3 receptor (DRD3) antagonist with an in vitro affinity approximately 100 times higher for dopamine D3 receptors than for D2 receptors. |
別名 | ABT 925, LU201640, ABT925, ABT-925, BSF201640, DAT201 |
分子量 | 608.63 |
分子式 | C24H35F3N6O7S |
CAS No. | 1160247-85-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
ABT-925 fumarate dihydrate 1160247-85-7 LU-201640 ABT 925 ABT 925 fumarate dihydrate ABT 925 Fumarate ABT-925 Fumarate ABT925 Fumarate DAT-201 LU 201640 LU201640 BSF 201640 ABT925 fumarate dihydrate ABT-925 fumarate Dihydrate DAT 201 ABT925 BSF-201640 ABT-925 BSF201640 DAT201 Inhibitor inhibitor inhibit